| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 77196-00-0 | Echinomycin 2QN (9CI); QuinomycinA,1-[N-(2-quinolinylcarbonyl)-D-serine]-5-[N-(2-quinolinylcarbonyl)-D-serine]-; 9,22-Dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosane, cyclicpeptide deriv. |  | C53H66N10O12S2 | 詳情 | 供應(yīng)商 | |
| 512-64-1 | 棘霉素 | Quinomycin A (7CI,9CI); Echinomycin(8CI); 9,22-Dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosane,cyclic peptide deriv.; Antibiotic A 654I; NSC 13502; NSC 526417; SK 302B; Stereoisomer ofN,N'-[2,4,12,15,17,25-hexamethyl-11,24-bis(1-methylethyl)-27-(methylthio)-3,6,10,13,16,19,23,26-octaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosane-7,20-diyl]bis[2-quinoxalinecarboxamide] |  | C51H64N12O12S2 | 詳情 | 供應(yīng)商 |
| 13758-27-5 | Triostin A (8CI,9CI); 9,22-Dioxa-28,29-dithia-2,5,12,15,18,25-hexaazabicyclo[12.12.4]triacontane,cyclic peptide deriv.; L-Valine,N-(2-quinoxalinylcarbonyl)-D-seryl-L-alanyl-N-methyl-L-cysteinyl-N-methyl-,bimol. (4® 1'),(4'® 1)-dilactone, cyclic (3® 3')-disulfide; N-(2-Quinoxalinylcarbonyl)-D-seryl-L-alanyl-N-methyl-L-cysteinyl-N-methyl-L-valinebimol. (4® 1'),(4'® 1)-dilactone cyclic (3® 3')-disulfide; NSC 244425 |  | C50H62N12O12S2 | 詳情 | 供應(yīng)商 | |
| 10382-35-1 | Triostin C; 9,22-Dioxa-28,29-dithia-2,5,12,15,18,25-hexaazabicyclo[12.12.4]triacontane,cyclic peptide deriv.; L-Leucine,N-(2-quinoxalinylcarbonyl)-D-seryl-L-alanyl-N-methyl-L-cysteinyl-N,3-dimethyl-,bimol. (4® 1'),(4'® 1)-dilactone, cyclic (3® 3')-disulfide; N-(2-Quinoxalinylcarbonyl)-D-seryl-L-alanyl-N-methyl-L-cysteinyl-N,3-dimethyl-L-leucinebimol. (4® 1'),(4'® 1)-dilactone cyclic (3® 3')-disulfide |  | C54H70N12O12S2 | 詳情 | 供應(yīng)商 | |
| 64189-50-0 | 3,6,10,13,16,19-hexaazabicyclo[6.6.6]eicosane; Sar; Sarcophagine; Sarcophagine (ligand) |  | C14H32N6 | 詳情 | 供應(yīng)商 |